Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      argenx to Present at Upcoming Investor Conferences
      Biotech

      argenx to Present at Upcoming Investor Conferences

      November 3, 2026
      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
      Biotech

      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

      November 2, 2026
      Mesoblast Board Changes
      Biotech

      Mesoblast Board Changes

      November 2, 2026
      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
      Biotech

      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

      November 2, 2026
      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
      Biotech

      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE

      October 31, 2026
      Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
      Biotech

      Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

      October 30, 2026
      Fortrea Reports Third Quarter 2026 Results
      Biotech

      Fortrea Reports Third Quarter 2026 Results

      October 29, 2026
      Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
      Biotech

      Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

      October 29, 2026
      Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)
      Biotech

      Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)

      October 29, 2026
      Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement
      Biotech

      Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement

      October 28, 2026
      « 1 2 3 4 5 6 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026